HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Trimethylamine oxide

HCID 1145
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1184-78-7
Standard SMILES
C[N+](C)(C)[O-]
InChIKey
UYPYRKYUKCHHIB-UHFFFAOYSA-N
Molecular formula
C3H9NO
Average molar mass
75.11 g/mol
Monoisotopic mass
75.06841391

Overview

Trimethylamine N-oxide is a tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine. It has a role as a metabolite, an osmolyte and an Escherichia coli metabolite. It is functionally related to a trimethylamine. It is a conjugate base of a hydroxytrimethylaminium.

Names & identifiers

Preferred name
Trimethylamine oxide
IUPAC
N,N-dimethylmethanamine oxide
English name
Trimethylamine N-oxide
Molecular formula
C3H9NO
Molecular weight
75.11

Names & synonyms

TRIMETHYLAMINE N-OXIDETrimethylamine oxide1184-78-7N,N-dimethylmethanamine oxideTrioxTrimethyloxamineTMAON,N-Dimethylmethanamine N-oxideMethanamine, N,N-dimethyl-, N-oxidetrimethylammonium oxide(CH3)3NOFLD0K1SJ1A
Show more names
Trimetlylamine OxideTrimethylamine N-Oxide AnhydrousTMANO AnhydrousTRIMETHYLAMINOXIDErimethylamineN-oxide
NSC-408426CHEBI:15724FEMA NO. 4245RefChem:933449214-675-6Trimethylamine N-oxide dihydratetrimethylamine-N-oxideTrimethylamine, N-oxide

Database identifiers

CAS
1184-78-7、85408-49-7
PubChem CID
1145
DTXSID
DTXSID8049678
ChEBI
CHEBI:15724
UNII
FLD0K1SJ1A
EC Number
214-675-6、287-011-6
Nikkaji
J7.304K

Properties

Computed structural properties

XLogP
-0.3
Topological polar surface area
18.1 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
1
Rotatable bonds
0
Heavy atoms
5
Formal charge
0
Complexity
28.4

Experimental & physicochemical properties

Chemical ClassesNitrogen Compounds -> Amine Oxides
DrugsPharmaceuticals -> Metabolite of Levocarnitine
SpringerMaterials PropertiesSchoenflies notation
LogP-2.570
Food AdditivesFLAVORING AGENT OR ADJUVANT -> FDA Substance added to food
Flavoring AgentsEU Flavoring substances
Solubility · 3 items

454 mg/mL

Soluble in water

Soluble (in ethanol)

Melting Point95 - 99 °C
Physical Description · 4 items

Liquid

Colorless solid; Highly hygroscopic; [Merck Index]

Solid

Colourless to yellow solid; Odourless

Physicochemical properties

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Danger

H302 (71.8%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P264+P265, P270, P273, P280, P301+P317, P302+P352, P305+P354+P338, P317, P321, P330, P332+P317, P362+P364, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 188 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

H302+H332 (31.5%): Harmful if swallowed or if inhaled [Warning Acute toxicity, oral; acute toxicity, inhalation]

Hazard information

Regulatory Information · 5 items

Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)

Methanamine, N,N-dimethyl-, N-oxide is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Methanamine, N,N-dimethyl-, N-oxide are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Active Update: 03-04-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/25104

Methanamine, N,N-dimethyl-, N-oxide: Does not have an individual approval but may be used under an appropriate group standard

Amines, C12-16-alkyldimethyl, N-oxides: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Hazards SummaryThe dihydrate is CAS# 62637-93-8; May cause skin, eye, and respiratory tract irritation; [Merck Index] Safe when used as a flavoring agent in food; [JECFA] A skin and strong eye irritant; [Sigma-Aldrich MSDS]
Hazard Classes and Categories · 2 items

Acute Tox. 4 (57.6%)

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

Trimethylamine-N-oxide is biosynthesized in the liver from trimethylamine (TMA), which is derived from choline. Flavin monooxygenase 3 (FMO3) has been implicated in the oxidation of TMA since individuals with mutations in FMO3 present with accumulation of TMA levels, causing fish malodor syndrome. TMAO is secreted in the urine and is not metabolized any further.

MeSH Pharmacological ClassificationElectron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION).
Tissue LocationsEpidermis
Cellular LocationsCytoplasm

Uses & manufacturing

Uses · 2 items

Present in marine organisms; Used in organic synthesis (oxidizing agent); [Merck Index] Used to make quaternary ammonium compounds, as an insect attractant, and a warning agent for flammable gas; [ChemIDplus] Used as flavoring agent or adjuvant; [FDA]

TMAO is produced endogenously in the body. High levels are found in fish. It is a uremic toxic and an atherotoxin or atherogenic. It is also an osmolyte.

U.S. Production2020: <50,000 lb
Industry UsesNot Known or Reasonably Ascertainable
Use Classification · 2 items

Flavouring Agent -> FLAVOURING_AGENT -> JECFA Functional Classes

Flavoring Agents -> JECFA Flavorings Index

General Manufacturing Information · 2 items

Not Known or Reasonably Ascertainable

Methanamine, N,N-dimethyl-, N-oxide: ACTIVE

Related reactions

146 records
New reaction record
HRID 54580 reaction equation
HRID 54580As reactantuspto-grants-1997_04
HRID 66402 reaction equation
HRID 66402As reactantuspto-grants-1978_12
HRID 67014 reaction equation
HRID 67014As reactantuspto-grants-1982_08
HRID 67031 reaction equation
HRID 67031As reactantuspto-grants-1982_08
HRID 75087 reaction equation
HRID 75087As reactantuspto-grants-2014_09
HRID 76299 reaction equation
HRID 76299As reactantuspto-grants-2014_09
HRID 76300 reaction equation
HRID 76300As reactantuspto-grants-2014_09
HRID 76302 reaction equation
HRID 76302As reactantuspto-grants-2014_09
Page 1 of 19

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
Melting point
220 · 220-222 °C (lit.)
Boiling point
133.8 °C · 133.8°C (rough estimate)
Density
0.9301 · 0.9301 (rough estimate)
vapor pressure
23.5 Pa · 23.5Pa at 20℃
refractive index
1.4698 · 1.4698 (estimate)
FEMA
4245 · 4245 | TRIMETHYLAMINE OXIDE
FLAVIS Number
11.025 · 11.025 | Trimethylamine oxide
storage temp.
Hygroscopic, Room Temperature, under inert atmosphere
solubility
Chloroform, DMSO, Methanol (Slightly)
pka
4.65 · 4.65(at 25℃)
form
Solid
color
Pale Yellow
Odor
odorless
Water Solubility
793 g/L · 793g/L at 24.5℃
Merck
14 · 14,9711
JECFA Number
1614 · 1614
Stability
Hygroscopic
InChI
1S/C3H9NO/c1-4(2,3)5/h1-3H3
InChIKey
UYPYRKYUKCHHIB-UHFFFAOYSA-N
SMILES
C[N+](C)(C)[O-]
LogP
-2.79 · -2.79
Substances Added to Food (formerly EAFUS)
TRIMETHYLAMINE OXIDE
EWG's Food Scores
1 · 1
FDA UNII
0 K1SJ1A · FLD0K1SJ1A
EPA Substance Registry System
Methanamine, N,N-dimethyl-, N-oxide (1184-78-7)
UNSPSC Code
12352116 · 12352116
NACRES
22 · NA.22
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302+H332
Precautionary statements
261 · P261-P264-P270-P271-P301+P312-P304+P340+P312
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xi
Risk Statements
36 · 36/37/38
Safety Statements
26 · 26-37/39
WGK Germany
3 · 3
TSCA
TSCA listed
HS Code
2904.2 · 2904.20.5000
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 InhalationAcute · Acute Tox. 4 InhalationAcute Tox. 4 Oral
REACH Registrations
Active

Acute Tox. 4 (71.8%)

Safety & protection

Minimum Risk Level>75 uM in blood

Toxicology

Treatment · 1 item

Kidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored. Treatments for atherosclerosis may include lifestyle changes (exercise, eating fruits and vegetables), medicines (statins), and medical procedures or surgery (angioplasty).

Health Effects · 1 item

High endogenous levels of TMAO in the blood (>100 uM) can lead to uremia which can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease. Chronically high levels of TMAO in the blood can also lead to the development of atherosclerosis and atherosclerotic plaques.

Exposure RoutesEndogenous, Ingestion
Toxicity Summary · 1 item

Uremic toxins such as TMAO are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (5). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (6). TMAO appears to contribute to the development of atherosclerosis in part by promoting cholesterol accumulation within macrophages, perhaps by inducing scavenger receptors such as CD36 and SRA1, both of which are involved in the uptake of modified lipoproteins (A15344).

Signs and Symptoms · 1 item

As a uremic toxin, TMAO can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present. Symptoms of atherosclerosis include angina, chest pain, breathlessness, nausea, dizziness, leg pains, weakness or numbness in the legs, erectile dysfunction, hairloss on legs or feet and leg sores that never heal.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity Data>100 uM in blood is usually indicative of uremia

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
tsca
TSCA listed
hs_code
2904.20.5000
risk_code
36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xi
safety_code
26-37/39
Storage Class
11 - Combustible Solids
Hazard statements
H302+H332
REACH Registrations
Active
Hazard Classifications
Acute Tox. 4 InhalationAcute Tox. 4 Oral
Precautionary statements
P261-P264-P270-P271-P301+P312-P304+P340+P312
Applications · 3 items

DescriptionTrimethylamine N-oxide (TMAO) is a metabolite of choline, phosphatidylcholine, and L-carnitine . It is formed by gut microbiota-mediated metabolism of choline, phosphatidylcholine, and L-carnitine to TMA followed by oxidation of TMA by flavin-containing monooxygenase 3 (FMO3) in the liver. Dietary administration of TMAO (0.12% w/w) increases renal tubulointerstitial fibrosis, collagen deposition, and Smad3 phosphorylation in mice and increases aortic lesion area in atherosclerosis-prone ApoE-/- mice. Plasma levels of TMAO are elevated in patients with chronic kidney disease and decreased in patients with active, compared with inactive, ulcerative colitis. Elevated plasma levels of TMAO are associated with increased risk of cardiovascular disease.

UsesTrimethylamineN-oxide can be used:As a demetallationand decarbonylationreagent for organometallic compounds.To prepare azomethine ylide by reaction with lithium di-isopropylamide. This, in turn, may be reacted with simple alkenes to obtain corresponding pyrrolidines.To mediate the conversion of thiols to disulfides.

General DescriptionTrimethylamineN-oxide is an organic compound that belongs to the class of amine oxides. It is generally found in the tissues of marine organisms, wherein it helps protect them from harsh conditions like salinity, hydrostatic pressure, temperature, and high urea.

Upstream & downstream products

Upstream raw materials

Hydrogen peroxideTolueneTrimethylamine

Downstream products

N,N'-Dimethylpiperazine2-Dimethylaminomethylphenol (contains phenol)(1-methylpyrrolidin-3-yl)methanol

Additional notes

DefinitionChEBI: An N-oxide derived from triethylamine.